OPK Opko Health
- 1.260
- +0.040+3.28%
- 1.250
- -0.010-0.79%
Opko Health News
Opko Health Options Spot-On: On April 10th, 97,755 Contracts Were Traded, With 357.21K Open Interest
On April 10th ET, $Opko Health(OPK.US)$ had active options trading, with a total trading volume of 97,755 options for the day, of which put options accounted for 48.89% of the total transactions, and
Opko Health Options Spot-On: On April 9th, 98,406 Contracts Were Traded, With 261.28K Open Interest
On April 9th ET, $Opko Health(OPK.US)$ had active options trading, with a total trading volume of 98,406 options for the day, of which put options accounted for 42.71% of the total transactions, and c
Opko Health Options Spot-On: On April 8th, 55,697 Contracts Were Traded, With 211.19K Open Interest
On April 8th ET, $Opko Health(OPK.US)$ had active options trading, with a total trading volume of 55,697 options for the day, of which put options accounted for 42.48% of the total transactions, and c
Opko Health Buy Rating Backed by Strategic Asset Sale and Promising Oral Drug Candidate
Express News | HC Wainwright & Co. Reiterates Buy on OPKO Health, Maintains $3 Price Target
OPKO Health (OPK) to Restructure After Asset Buyout by Labcorp
Critical Insights From OPKO Health Analyst Ratings: What You Need To Know
Across the recent three months, 4 analysts have shared their insights on OPKO Health (NASDAQ:OPK), expressing a variety of opinions spanning from bullish to bearish.The following table encapsulates th
OPKO Health Is Maintained at Outperform by Barrington Research
OPKO Health Is Maintained at Outperform by Barrington Research
Express News | Barrington Research Maintains Outperform on OPKO Health, Maintains $1.5 Price Target
OPKO Health Price Target Maintained With a $5.00/Share by Piper Sandler
OPKO Health Price Target Maintained With a $5.00/Share by Piper Sandler
OPKO Health Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 04/01/2024 296.79% Piper Sandler → $5 Reiterates Overweight → Overweight 02/28/2024 138.08% HC Wainwright
Buy Rating Affirmed for Opko Health Amid Strategic Divestiture and Operational Improvement Prospects
Analysts Offer Insights on Healthcare Companies: Alkermes (ALKS), Opko Health (OPK) and Leafly Holdings, Inc. (LFLY)
Express News | OPKO Health Shares Are Trading Higher After Labcorp Announced It Will Acquire Select Assets of OPKO's BioReference Health for a Purchase Price of $237.5 Million
REX American Resources Reports Upbeat Earnings, Joins Avalo Therapeutics, RH And Other Big Stocks Moving Higher On Thursday
REX American Resources Reports Upbeat Earnings, Joins Avalo Therapeutics, RH And Other Big Stocks Moving Higher On Thursday
Opko Health Sells Diagnostics Business to LabCorp
Labcorp to Buy Some Lab-Testing Businesses From OPKO Health for $237.5 Million
By Will Feuer Laboratory Corporation of America, also called Labcorp, has agreed to buy certain laboratory testing businesses for $237.5 million from a subsidiary of OPKO Health, a move by the diagno
Labcorp to Buy Some Assets of OPKO's BioReference Health Unit >LH OPK
Labcorp to Buy Some Assets of OPKO's BioReference Health Unit >LH OPK
Labcorp Announces Acquisition of Select Assets of BioReference Health's Diagnostics Business
Labcorp Announces Acquisition of Select Assets of BioReference Health's Diagnostics Business
Entera Bio Announces Robust Pharmacokinetic Data for First-in-Class Oral GLP-2 Peptide Tablet...
Analysis
Price Target
No Data
